Table 1 Pharmacokinetic profile of AZ889 with P.O. administration
From: Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain
Dose (μmol/kg) | Cmax (μM) | Tmax (h) | Bioavailability (%) |
|---|---|---|---|
35.03 | 0.172 | 4 | 13.9 |
From: Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain
Dose (μmol/kg) | Cmax (μM) | Tmax (h) | Bioavailability (%) |
|---|---|---|---|
35.03 | 0.172 | 4 | 13.9 |